Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | FGFR3 S249C |
Therapy | Pembrolizumab + Pemigatinib |
Indication/Tumor Type | bladder urothelial carcinoma |
Response Type | predicted - sensitive |